CMS Extends Drug Pricing Program Deadlines Amid Demand
WASHINGTON, D.C. — Federal health officials have pushed back key deadlines for a new Medicaid drug pricing initiative after strong interest from pharmaceutical manufacturers and state programs.
CMS Extends Drug Pricing Program Deadlines Amid Demand Read More